Rare diseases Xagena
Aggiornamento in Medicina
The FDA ( Food and Drug Administration ) has announced the approval of Lumizyme ( Alglucosidase alfa ) for treatment of patients with infantile-onset Pompe disease, including patients who are less tha ...
